Intraperitoneal P-32 is not an effective consolidation therapy after a negative second-look laparotomy for epithelial carcinoma of the ovary
- 30 November 1992
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 47 (2) , 146-149
- https://doi.org/10.1016/0090-8258(92)90098-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapyGynecologic Oncology, 1991
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Survival of patients with ovarian epithelial carcinomas after second-look laparotomyGynecologic Oncology, 1990
- Intraperitoneal P-32 after negative second-look laparotomy in ovarian carcinomaCancer, 1989
- Intraperitoneal chromic phosphate in ovarian cancer: Risks and benefitsGynecologic Oncology, 1989
- Recurrence after negative second-look laparotomy for ovarian cancer: Analysis of risk factorsAmerican Journal of Obstetrics and Gynecology, 1988
- Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancerCancer, 1988
- Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinomaGynecologic Oncology, 1988
- A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group studyCancer, 1986
- Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinCancer, 1981